- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Mucosal Impedance in Pediatric Population (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=127, Completed, Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Completed | N=198 --> 127 | Trial primary completion date: Dec 2016 --> Sep 2016
- |||||||||| Trial completion, Enrollment change, Trial primary completion date, Reflex: Cough Reflex Sensitivity and Bronchial Hyper-responsiveness (clinicaltrials.gov) - Feb 17, 2017
P=N/A, N=24, Completed, Recruiting --> Completed | N=198 --> 127 | Trial primary completion date: Dec 2016 --> Sep 2016 Recruiting --> Completed | N=36 --> 24 | Trial primary completion date: Dec 2016 --> Feb 2016
- |||||||||| prednisone / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Reduction in Symptomatic Esophageal Stricture Formation (clinicaltrials.gov) - Feb 14, 2017 P4, N=3, Completed, Recruiting --> Completed | N=36 --> 24 | Trial primary completion date: Dec 2016 --> Feb 2016 Recruiting --> Completed | N=126 --> 3 | Trial primary completion date: Mar 2017 --> Feb 2015
- |||||||||| Trial primary completion date, Metastases: ATTACK-OG: NY-ESO-1 T Cells in OG Cancer (clinicaltrials.gov) - Feb 8, 2017
P2, N=28, Active, not recruiting, Recruiting --> Completed | N=20 --> 12 Trial primary completion date: Dec 2016 --> Dec 2018
- |||||||||| Phase classification: RELIEF Europe Study (clinicaltrials.gov) - Feb 6, 2017
P=N/A, N=7, Terminated, Trial primary completion date: Jun 2017 --> Feb 2018 Phase classification: P4 --> P=N/A
- |||||||||| oxaliplatin / Generic mfg., capecitabine / Generic mfg., albumin-bound paclitaxel / Generic mfg.
Enrollment closed, Trial primary completion date, Metastases: The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION) (clinicaltrials.gov) - Jan 26, 2017 P1/2, N=154, Active, not recruiting, Recruiting --> Active, not recruiting | N=16 --> 12 | Trial primary completion date: Jun 2012 --> Aug 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Sep 2017
- |||||||||| Trial primary completion date, FDG PET: 4D FDG PET in Esophageal Cancer (clinicaltrials.gov) - Jan 23, 2017
P=N/A, N=30, Recruiting, Trial primary completion date: Jan 2009 --> Jul 2005 Trial primary completion date: Dec 2016 --> Dec 2017
- |||||||||| Trial completion, Trial primary completion date: Transparent Cap-assisted Endoscopic Sclerotherapy (clinicaltrials.gov) - Jan 17, 2017
P=N/A, N=120, Completed, Recruiting --> Completed | N=18 --> 80 Not yet recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2016
- |||||||||| Trial completion, Enrollment change, Trial primary completion date, Surgery: Prospective Pediatric Vesicoureteral Reflux Surgery Database (clinicaltrials.gov) - Jan 5, 2017
P=N/A, N=134, Completed, N=100 --> 50 Recruiting --> Completed | N=200 --> 134 | Trial primary completion date: Jul 2012 --> Nov 2016
|